Incentivizing Adherence to Improve Outcomes in a Hepatitis C Virus (HCV) Treatment Trial: Results from the Kentucky Viral Hepatitis Treatment (KeY Treat) Study

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Incentivizing Adherence to Improve Outcomes in a Hepatitis C Virus (HCV) Treatment Trial: Results from the Kentucky Viral Hepatitis Treatment (KeY Treat) Study

	AASLD 2026 Denver